Home › Funds › Royce & Associates › STIM
Royce & Associates position in STIM
NEURONETICS INC · Health Care
Latest position (Q1 2022)253.50K sh
Reported value held$768.00K
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 336.50K | $2.21M | New |
| Q4 2021 | 386.50K | $1.72M | Add |
| Q1 2022 | 253.50K | $768.00K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STIM
- Vanguard Group 2.58M sh · $3.56M · Q4 2025
- UBS Group AG 2.28M sh · $2.96M · Q2 2026
- BlackRock Inc 596.62K sh · $775.61K · Q2 2026
- Marshall Wace 485.69K sh · $631.40K · Q2 2026
- Geode Capital Management 458.47K sh · $596.24K · Q2 2026
- Goldman Sachs Group 264.09K sh · $343.31K · Q2 2026
- Millennium Management 199.45K sh · $259.29K · Q2 2026
- AQR Capital Management 117.82K sh · $153.17K · Q2 2026
- Northern Trust Corp 89.14K sh · $115.88K · Q2 2026
- Invesco Ltd 68.34K sh · $88.84K · Q2 2026
- Bank of America Corp 68.19K sh · $88.65K · Q2 2026
- Morgan Stanley 62.89K sh · $81.76K · Q2 2026